The thiazolidinedione, troglitazone. does not initiate ventricular cardiomyocyte hypertrophy in vitro but may sensitise cardiomyocytes to the hypertrophic effects of serum growth factors

David Bell; Barbara McDermott

The thiazolidinedione, troglitazone. does not initiate ventricular cardiomyocyte hypertrophy in vitro but may sensitise cardiomyocytes to the hypertrophic effects of serum growth factors

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	237-244
Number of pages	8
Journal	European Journal of Pharmacology
Volume	390
Publication status	Published - 01 Oct 2000

Cite this

@article{4a2e673646624b7fabd5646383595527,

title = "The thiazolidinedione, troglitazone. does not initiate ventricular cardiomyocyte hypertrophy in vitro but may sensitise cardiomyocytes to the hypertrophic effects of serum growth factors",

author = "David Bell and Barbara McDermott",

year = "2000",

month = oct,

day = "1",

language = "English",

volume = "390",

pages = "237--244",

journal = "European Journal of Pharmacology",

issn = "0014-2999",

publisher = "Elsevier",

}

TY - JOUR

T1 - The thiazolidinedione, troglitazone. does not initiate ventricular cardiomyocyte hypertrophy in vitro but may sensitise cardiomyocytes to the hypertrophic effects of serum growth factors

AU - Bell, David

AU - McDermott, Barbara

PY - 2000/10/1

Y1 - 2000/10/1

M3 - Article

VL - 390

SP - 237

EP - 244

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

ER -